What is Cortagen?

A synthetic four-amino-acid peptide (Ala-Glu-Asp-Pro) investigated for effects on nerve tissue and gene expression.

Cortagen in the library · Bioregulator Peptides · Human Trials · What are peptides?

0 registered trials · 0 indexed papers · 3 human / 12 animal studies

From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.

What it is

Cortagen is characterized as a synthetic four-amino-acid peptide (Ala-Glu-Asp-Pro, AEDP) investigated for effects on nerve tissue and gene expression. It was developed through directed synthesis informed by the brain cortex peptide preparation Cortexin, within the Khavinson peptide bioregulator research program.

Its research history includes rat nerve-injury experiments, mouse studies and early patient reports in a patent, described as a more limited foundation than the confident claims about memory, brain fog and “brain repair” frequently attached to it.

Overview (as described)

  • Some experiments suggest biological activity; whether a particular product improves a meaningful outcome in people at an acceptable level of risk is described as unresolved.

More cited research

Related compounds

FAQ

What is Cortagen?

A synthetic four-amino-acid peptide (Ala-Glu-Asp-Pro) investigated for effects on nerve tissue and gene expression.

How many registered human trials study Cortagen?

The PeptideWhiz trial index lists 0 registered trials for Cortagen.

How much published research exists on Cortagen?

By study type, PeptideWhiz counts 3 human and 12 animal studies on Cortagen.

Which conditions is Cortagen researched for?

No condition pages are linked to this compound yet.

Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).